Back to search

Article

Novel CRISPR-Cas9 BAP1 Knockout Pre-Clinical Tumor Model Recapitulates Human Melanoma Tumorigenesis and Immune Evolution

2025-04-15

Abstract excerpt

<title>Abstract</title> <p>BAP1-deficient melanocytic tumors exhibit strong immunosuppressive features and poor prognosis. Currently, no immune-competent preclinical models exist to study their tumor-immune interactions or test new immunotherapies. This limitation hinders progress in understanding how BAP1 loss drives tumor aggressiveness and immune evasion. To address this, we generated a syngeneic BAP1 knockout...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dd5a706d-ab69-5f81-8c3e-9f1af7996af9
DOI
10.21203/rs.3.rs-6134890/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Novel CRISPR-Cas9 BAP1 Knockout Pre-Clinical Tumor Model Recapitulates Human Melanoma Tumorigenesis and Immune EvolutionDOI 10.21203/rs.3.rs-6134890/v2
Select a neighboring publication to make it the new centre.